Sat.Nov 27, 2021 - Fri.Dec 03, 2021

article thumbnail

Trial of Jazz’ cannabis drug in glioblastoma will start next year

pharmaphorum

An investigator-led trial of Jazz Pharma’s cannabis extract-based drug Sativex in glioblastoma – an aggressive form of brain cancer – will get underway in the UK next year. The three-year phase 2 trial will be carried out by researchers at Leeds University led by professor of clinical oncology and neuro-oncology Susan Short, and see if adding Sativex (nabiximols) to standard chemotherapy for recurrent glioblastoma can extend survival.

article thumbnail

After court-ordered injunctions, Cleveland Clinic, HCA and other providers hit pause on workforce vaccine mandates

Fierce Healthcare

After court-ordered injunctions, Cleveland Clinic, HCA and other providers hit pause on workforce vaccine mandates. dmuoio. Fri, 12/03/2021 - 16:30.

Vaccines 135
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Gain Therapeutics presents hopeful data for Parkinson’s, Gaucher treatment

Outsourcing Pharma

The biotech firm has presented data from a study that could offer hope to patients with Parkinsonâs, Gaucher, Alzheimerâs and other neurodegenerative conditions.

115
115
article thumbnail

Ep. 016 How Biotech and Pharma Companies are Using Technology to Improve CX – Jennifer Ginest and Robert Schildt of Biohaven Pharmaceuticals

Pharma Marketing Network

Tune in to this episode of the Pharma Marketing Podcast to hear from our guest, Robert Schildt, Senior Director of Go-To-Market Innovation at Biohaven Pharmaceuticals and Jennifer Ginest, Digital Marketing Manager of PMN discuss how digital is being used to engage and personalize the CX experience in pharma.

52
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Boehringer-backed digital health academy set for launch in UK

pharmaphorum

An online training academy that aims to raise the digital skills of NHS health and care workers is due to open its virtual doors next March, according to the Organisation for the Review of Care and Health Apps (ORCHA). The Digital Health Academy – developed with pharma company Boehringer Ingelheim – is part of a drive to get digital health tools and apps used more routinely in the management of health conditions, according to ORCHA.

121
121
article thumbnail

Out-of-pocket costs may play larger role in telehealth visits than in-person care: survey

Fierce Healthcare

Out-of-pocket costs may play larger role in telehealth visits than in-person care: survey. rtorrence. Fri, 12/03/2021 - 16:07.

145
145

More Trending

article thumbnail

Market Intelligence for Emerging Markets

Fuld

Why is market intelligence important? Market intelligence is important for any company – whether that company is seeking growth or just working to maintain share. Markets are dynamic and any number of asymmetric and unknown forces can be at play. Typically, clients are looking for market insight when they are about to make an investment, forge a partnership or change their go-to market strategy.

article thumbnail

MHRA okays GSK’s Xevudy as data suggest it works against Omicron

pharmaphorum

The UK medicines regulator has approved GlaxoSmithKline and Vir Biotech’s antibody for COVID-19, Xevudy, which has been shown to be effective against the new Omicron strain of SARS-CoV-2 in lab testing. Xevudy (sotrovimab) is the second COVID-19 antibody to be approved by the MHRA after Roche/Regeneron’s Ronapreve (casirivimab and imdevimab), which got a green light during the summer.

Vaccines 119
article thumbnail

Carbon Health launches new program with continuous glucose monitors to assess diabetes risk

Fierce Healthcare

Carbon Health launches new program with continuous glucose monitors to assess diabetes risk. rtorrence. Wed, 12/01/2021 - 17:47.

144
144
article thumbnail

Decentralized format dramatically transforming clinical research: ICON

Outsourcing Pharma

An expert from the ]contract research organization discusses the impact virtual trials have had on the industry, and how that transformation is likely to continue.

104
104
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

2022 membership for microbiologists and those working alongside them

Pharmig

It’s now time for Pharmig to look forward into 2022 and update our event portfolio. The post 2022 membership for microbiologists and those working alongside them appeared first on Pharmig.

52
article thumbnail

AZ eyes FDA verdict on Lynparza in adjuvant breast cancer in Q1

pharmaphorum

The FDA will deliver a verdict on AstraZeneca’s PARP inhibitor Lynparza as an adjuvant treatment for breast cancer in the first quarter of next year, after granting the application a priority review. AZ and partner Merck & Co have filed Lynparza (olaparib) for use in BRCA-mutated, HER2-negative early breast cancer in patients who have already been treated with chemotherapy either before or after surgery and are at high risk of the disease coming back.

FDA 111
article thumbnail

HHS: Telehealth use in Medicare increased 63-fold last year with behavioral health increasing the most

Fierce Healthcare

HHS: Telehealth use in Medicare increased 63-fold last year with behavioral health increasing the most. rking. Fri, 12/03/2021 - 16:14.

137
137
article thumbnail

GSK and University of Oxford launch new institute, embracing advanced technologies for drug discovery

Outsourcing Pharma

The Oxford-GSK Institute of Molecular and Computational Medicine has been created via a five-year collaboration between GlaxoSmithKline and the University of Oxford.

96
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Benefits of Using Compounding Services

Lifewell Rx Pharmacy

As we age, we require more and more medication to keep our bodies healthy and strong, this is also true for people with severe illnesses that have to be treated with prescription medication. But sometimes, these medicines get discontinued or patients are allergic to some of their ingredients, making it hard to simply walk into a Retail Pharmacy and buy what they need off the shelves.

article thumbnail

Novartis takes aim at risky Parkinson’s target with $1.5bn UCB deal

pharmaphorum

Novartis has licensed a potential drug for Parkinson’s from Belgium’s UCB that it thinks could be the first oral, disease-modifying drug for the disease – if it can avoid the fate of earlier drugs in the class. The drug – called UCB0599 – targets a protein called alpha synuclein that tends to get misfolded and accumulates into clumps in the brains of Parkinson’s patients, and is thought to damage neurons – somewhat analogous to amyloid and tau proteins in Alzheimer’s dise

article thumbnail

AMA: Medicare physician fee schedule spending dropped nearly $14B last year due to COVID-19

Fierce Healthcare

AMA: Medicare physician fee schedule spending dropped nearly $14B last year due to COVID-19. rking. Fri, 12/03/2021 - 12:25.

141
141
article thumbnail

Decentralized format can help elevate trial inclusivity: Science 37

Outsourcing Pharma

An expert from the decentralized clinical trial solutions provider discusses how the virtual format and technology can help improve study representation.

81
article thumbnail

Cell and Gene Therapy Bioassay – A Prerequisite for the ATMPs Development

Roots Analysis

Bioassay – A Prerequisite for the Cell and Gene Therapy Development. Over the past few years, investigational new drug (IND) filings for cell and gene therapy product have significantly increased. In fact, from year 2016 to 2020 more than 300 IND filing for cell and gene therapy product have been recorded, indicating that several developers and innovators are more attracted towards the cell and gene therapies.

52
article thumbnail

Pharma pledges rapid response to Omicron COVID variant

pharmaphorum

With governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened Omicron – leading vaccine manufacturers have said they are poised to develop new shots if needed. News of the new variant emerged last week, and has resulted in travel bans being imposed on various African countries by the US, EU and UK, among others.

Vaccines 111
article thumbnail

CVS inks tech partnership with Microsoft to accelerate its 'digital-first' strategy

Fierce Healthcare

CVS inks tech partnership with Microsoft to accelerate its 'digital-first' strategy. hlandi. Thu, 12/02/2021 - 06:26.

145
145
article thumbnail

AI-based blood analysis tool geared toward decentralized diagnostics

Outsourcing Pharma

With the release of its new Sight OLO artificial intelligence based blood analyzer, Sight Diagnostics hopes to offer DCTs reliable, easy-to-use testing.

75
article thumbnail

Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19

Pharma Mirror

Rockville, Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system. The ACTT-3 trial assessed the efficacy and safety of interferon beta-1a plus remdesivir compared to remdesivir alone in hospitalized adults with COVID-19.

article thumbnail

Trial closes gap between Bayer’s Nubeqa and rivals in prostate cancer

pharmaphorum

Bayer’s Nubeqa is making headway as a treatment for castration-resistant prostate cancer (CRPC), but could be on track to expand the eligible patient population for the drug thanks to new phase 3 data. Just released results from the ARASENS trial show that adding Nubeqa (darolutamide) to docetaxel chemotherapy and androgen deprivation therapy (ADT) to switch off testosterone production helps men with castration-sensitive prostate cancer (CSPC).

article thumbnail

Hack targets Planned Parenthood, exposing personal information of 400K patients

Fierce Healthcare

Hack targets Planned Parenthood, exposing personal information of 400K patients. rtorrence. Fri, 12/03/2021 - 10:13.

145
145
article thumbnail

Decentralized trials dramatically transforming clinical research: ICON

Outsourcing Pharma

An expert from the contract research organization discusses the impact decentralized trials have had on the industry, and how that transformation is likely to continue.

64
article thumbnail

Medinfar awarded first ever CPhI Verified Certificate

Pharma Mirror

CPhI awards the first ever CPhI Verified certificate to Medinfar – an international pharmaceutical manufacturer of Rx, cosmetics, food supplements and veterinary products. The new certification was given after a detailed evaluation by SGS – the world’s leading verification, inspection and certification company – spanning some 14 separate criteria, including the company’s approach to quality and environmental management, supply chain, health and safety and business continuity planning.

52
article thumbnail

15 traits of effective bosses and how to catalyse your team

pharmaphorum

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post looks at people manager effectiveness and how to boost team and co-worker engagement. It’s that special time in the annual corporate lifecycle: year-end performance reviews are being conducted around the globe, employee ratings allocated, calibrated and translated into salary increa

article thumbnail

Google rolls out new search tools for health information on Medicare services, languages spoken by providers

Fierce Healthcare

Google rolls out new search tools for health information on Medicare services, languages spoken by providers. rtorrence. Thu, 12/02/2021 - 10:59.

126
126
article thumbnail

Trial recruitment improving more rapidly in some populations than others: Phesi

Outsourcing Pharma

Patient data from the clinical solutions company indicates that gains in recruitment of Black participants is outpacing that of patients from other groups.

59
article thumbnail

The 2022 Future Forecast for Pharma Marketing (VIRTUAL – JAN 2022)

Pharma Marketing Network

If the last two years have taught us anything, it’s that everything can change in an instant, and in order to keep moving forward we need to adapt quickly to meet the new challenges head-on. Coming in January; join the Pharma Marketing Network and industry experts for a fire-side talk on hot topics around what has changed and how to align your pharma marketing strategies accordingly.

52
article thumbnail

Health Innovators: Senseonics’ Francine Kaufman

pharmaphorum

In the most recent of the Health Innovators video series, pharmaphorum’s founder, Dr Paul Tunnah, chats with the chief medical officer of Senseonics. Francine Kaufman discusses how Senseonics is helping patients monitor their diabetes with the first fully implantable long-term continuous glucose monitoring (CGM) system. Monitoring glucose values is necessary for diabetes patients, and technologically advanced systems make it much easier for patients to self-manage the disease, according to

105
105
article thumbnail

Federal judge halts CMS' COVID-19 vaccine mandate for healthcare workers in 10 rural states

Fierce Healthcare

Federal judge halts CMS' COVID-19 vaccine mandate for healthcare workers in 10 rural states. dmuoio. Mon, 11/29/2021 - 15:30.

Vaccines 137
article thumbnail

Protecting the pharma supply chain takes tech solutions: Pariveda

Outsourcing Pharma

A leader from the IT consulting company makes the case for digitization and explains the potenial benefits of bringing an operation into the 21st century.

59